• OPEN AN ACCOUNT
Indian Indices
Sensex
78,743.98 649.34
( 0.83%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
63,705.00 -657.02
(-1.02%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

ACC Ltd
Industry :  Cement - North India
BSE Code
ISIN Demat
Book Value()
500410
INE012A01025
1087.1955284
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ACC
13.2
25494
EPS(TTM)
Face Value()
Div & Yield %
102.84
10
0.55
 

Wanbury update on filing of DFM in US and South Korea
Jul 30,2026
Wanbury recently received “No DMF deficiency letter” from the office of USFDA (US Food and Drug Administration) for multiple ANDAs (Abbreviated New Drug Applications) with Metformin HCl API source of Wanbury for different formulations.

Further, Wanbury expanded business opportunities in South Korea for one more API by filing the DMF. Wanbury is committed for supply of best APIs to the new market for well-being of human being.